David Pryor

Results of a prospective study of positron emission tomography–directed management of residual nodal abnormalities in node‐positive head and neck cancer after definitive radiotherapy with or without systemic therapy

Sandro Porceddu, David Pryor, Elizabeth Burmeister et al. · Head & Neck · 2011 · 173 citations

Medicine, Nuclear Medicine, Oncology +16

Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial

Shankar Siva, Mathias Bressel, Simon Wood et al. · European Urology · 2021 · 149 citations

Medicine, Oncology, Radiation Oncology +13

Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer

David Pryor, Sandro Porceddu, Bryan Burmeister et al. · Radiotherapy and Oncology · 2008 · 123 citations

Pharmacy, Oncology, Radiation Oncology +14

Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial

Shankar Siva, Mathias Bressel, Mark Sidhom et al. · The Lancet Oncology · 2024 · 105 citations

Medicine, Oncology, Radiation Oncology +13

Prevention Conference V

Sidney C. Smith, Ezra A. Amsterdam, Gary Balady et al. · Circulation · 2000 · 93 citations

Medicine, Cardiology, Internal Medicine +17